バイオ外科手術のアジア太平洋市場2021-2028

◆英語タイトル:ASIA-PACIFIC BIOSURGERY MARKET FORECAST 2021-2028
◆商品コード:INK21JU040
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2021年6月20日
◆ページ数:161
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートはバイオ外科手術のアジア太平洋市場について調査・分析し、調査範囲/手法、エグゼクティブサマリー、市場動向、主要分析、製品別分析、ソース別分析、用途別分析、地域別分析、競争状況などを掲載したものです。
【レポートの概要】

KEY FINDINGSThe Asia-Pacific biosurgery market is anticipated to record a CAGR of 7.46% during the forecast period, 2021-2028. The surging aging population and numerous lifestyle conditions raise the demand for biosurgery products, which boosts market growth.
MARKET INSIGHTS
Indonesia, Australia & New Zealand, Japan, India, China, Vietnam, South Korea, Thailand, and Rest of Asia-Pacific are assessed for the Asia-Pacific biosurgery market growth analysis. In Japan, the increasing number of surgical procedures and geriatric population drives the market growth. Japan is home to one of the highest percentages of the older population. As per the World Ageing Population, almost 35,524,000 people were aged 65 and above in 2019, which is slated to increase further by 2050. As a result, the chronic disease incidence and long-term and healthcare expenditures are set to grow. Moreover, the rising aesthetic procedures and the growth strategies adopted by companies benefit market growth.
In Thailand, the increased number of aesthetic procedures contributes to market growth. As per the International Society of Aesthetic and Plastic Surgery report, almost 92,597 surgical aesthetic procedures were performed in 2019. It is also the most sought country for medical tourism, given its liberal medical visa policies and cost-effective medical surgeries. In 2018, medical tourism accounted for 0.4% of the GDP in Thailand as per the International Trade Administration. Furthermore, the country’s healthcare expenditure has increased steadily over the years. Several huge conglomerate companies are inclined to invest in healthcare, thereby benefiting market growth. Such factors facilitate market growth in these countries.
COMPETITIVE INSIGHTS
Some of the prominent market players include RTI Surgical, CSL Limited, Cryolife Inc, Integra Lifesciences Holdings Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. PREVALENCE OF GERIATRIC POPULATION
3.1.2. ADVANCEMENTS IN TECHNOLOGY
3.1.3. INCIDENCE OF MUSCULOSKELETAL DISORDERS
3.1.4. SURGE IN RESEARCH AND DEVELOPMENT
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF SURGERIES
3.2.2. RISK ASSOCIATED WITH IMMUNE RESPONSE
3.2.3. GROWING POPULARITY OF MINIMALLY INVASIVE PROCEDURES
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON BIOSURGERY MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. KEY BUYING CRITERIA
4.5. KEY INSIGHTS
4.6. OPPORTUNITY MATRIX
4.7. VENDOR LANDSCAPE
5. MARKET BY PRODUCT
5.1. HEMOSTATIC AGENTS
5.2. BONE-GRAFT SUBSTITUTES
5.2.1. SYNTHETIC GRAFT EXTENDERS
5.2.2. DEMINERALIZED BONE MATRIX
5.2.3. BONE MORPHOGENETIC PROTEINS
5.2.4. CELL-BASED MATRICES
5.3. SURGICAL SEALING AGENTS
5.3.1. NATURAL
5.3.2. SYNTHETIC
5.4. SOFT-TISSUE MANAGEMENT
5.4.1. SYNTHETIC MESH/PATCH
5.4.2. NATURAL MESH/PATCH
5.5. ANTI-ADHESIVE AGENTS
5.6. STAPLE LINE REINFORCEMENT
6. MARKET BY SOURCE TYPE
6.1. NATURAL
6.2. SYNTHETIC
7. MARKET BY APPLICATION
7.1. ORTHOPEDIC SURGERY
7.2. CARDIO AND THORACIC SURGERY
7.3. NEURO AND SPINE SURGERY
7.4. GENERAL SURGERY
7.5. OTHER APPLICATIONS
8. GEOGRAPHICAL ANALYSIS
8.1. ASIA-PACIFIC
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLER
8.1.3. KEY CHALLENGE
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. CHINA
8.1.5.2. JAPAN
8.1.5.3. INDIA
8.1.5.4. AUSTRALIA & NEW ZEALAND
8.1.5.5. SOUTH KOREA
8.1.5.6. THAILAND
8.1.5.7. INDONESIA
8.1.5.8. VIETNAM
8.1.5.9. REST OF ASIA-PACIFIC
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. BAXTER INTERNATIONAL INC
9.2.2. B BRAUN MELSUNGEN AG
9.2.3. BECTON, DICKINSON AND COMPANY (C R BARD)
9.2.4. BETATECH MEDICAL
9.2.5. CSL LIMITED
9.2.6. CRYOLIFE INC
9.2.7. ETHICON INC (JOHNSON & JOHNSON)
9.2.8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9.2.9. MEDTRONIC PLC
9.2.10. RTI SURGICAL
9.2.11. SANOFI
9.2.12. SMITH & NEPHEW PLC
9.2.13. STRYKER CORPORATION
9.2.14. WRIGHT MEDICAL GROUP NV
9.2.15. ZIMMER BIOMET HOLDINGS INC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - BIOSURGERY
TABLE 2: ASIA-PACIFIC BIOSURGERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC BIOSURGERY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC BIOSURGERY MARKET, BY SOURCE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC BIOSURGERY MARKET, BY SOURCE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC BIOSURGERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC BIOSURGERY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: LEADING PLAYERS OPERATING IN ASIA-PACIFIC BIOSURGERY MARKET
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: ASIA-PACIFIC BIOSURGERY MARKET, BY PRODUCT, IN 2020
FIGURE 6: ASIA-PACIFIC BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC BIOSURGERY MARKET, BY SOURCE TYPE, IN 2020
FIGURE 21: ASIA-PACIFIC BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC BIOSURGERY MARKET, BY APPLICATION, IN 2020
FIGURE 24: ASIA-PACIFIC BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC BIOSURGERY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 30: CHINA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: JAPAN BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: INDIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 33: AUSTRALIA & NEW ZEALAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: SOUTH KOREA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: THAILAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 36: INDONESIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 37: VIETNAM BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 38: REST OF ASIA-PACIFIC BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[バイオ外科手術のアジア太平洋市場2021-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆